1st Circuit Denies Rehearing In Securities Suit Against Drug Company

Mealey's (October 13, 2017, 10:02 AM EDT) -- BOSTON — The First Circuit U.S. Court of Appeals denied a petition for rehearing and rehearing en banc in a securities class action filed by a pharmaceutical company’s shareholders who alleged...
To view the full article, register now.